Pharmaceutical compositions containing dextrorphan for intranasal application
US5019579A · kind A · utility
0Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 7, 1989 |
| Grant date | May 28, 1991 |
| Priority date | — |
| Expiry date | Dec 7, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0043
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The object of the invention is a pharmaceutically acceptable composition suitable to achieve a systemic therapeutical response due to its antitussis action in warm-blooded animals, characterized in that it contains, per dosage unit: (I) an amount therapeutically efficacious by systemic way due to the antitussis action of salified dextrorphan, and (II) a pharmaceutically non-toxic excipient acceptable for intranasal administering.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.